ALSO NOTED: Novasite buys PsyCheNomicS; AstraZeneca fined; Corixa shareholder balks at buyout; and much more...

> San Diego-based Novasite has acquired PsyCheNomicS for an undisclosed amount. PsyCheNomicS has been developing treatments for the central nervous system. Release

> AstraZeneca has been fined £40 million by the European Commission for blocking generic versions of Prilosec. Article

> A major shareholder of Corixa says it will vote against GlaxoSmithKline's proposed acquisition, saying the bid was undervalued. Release

> The FDA has approved an expansion of the Angiomax label for more types of angioplasty procedures. Story

> Houston-based Fabre-Kramer has reacquired the rights to Gepirone ER, a once-daily product being developed for the treatment of depression. Release

> Spectrum Pharmaceuticals says the FDA has approved its generic version of Bristol-Myers Squibb's Paraplatin. Article

> The proposed merger between Genzyme and Bone Care International has cleared the FTC. Release

And Finally... Hundreds of doctors have taken the pledge on to shun drug companies' freebies. Story